Intelligence · Clinical Development
Pipeline search results
Programs matching “roflumilast” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 20 pipeline programs matching "roflumilast" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Roflumilast
AstraZeneca
Asthma
1 trial -
Roflumilast
AstraZeneca
COPD
1 trial -
Roflumilast 0.3% cream
Arcutis Biotherapeutics
Chronic Plaque Psoriasis
1 trial -
Roflumilast Cream
Arcutis Biotherapeutics
Atopic Dermatitis Eczema
1 trial -
Roflumilast Cream 0.05%
Arcutis Biotherapeutics
Atopic Dermatitis Eczema
1 trial -
Roflumilast Cream 0.15%
Arcutis Biotherapeutics
Atopic Dermatitis Eczema
1 trial -
Roflumilast Foam
Arcutis Biotherapeutics
Seborrheic Dermatitis
1 trial -
Roflumilast Foam 0.3%
Arcutis Biotherapeutics
Scalp Psoriasis
1 trial -
Topical roflumilast
Arcutis Biotherapeutics
Chronic Plaque Psoriasis
1 trial -
Roflumilast
Takeda
Chronic Obstructive Pulmonary Disease
1 trial -
Roflumilast
Arcutis Biotherapeutics
Plaque Psoriasis
1 trial -
Roflumilast Cream 0.05%
Arcutis Biotherapeutics
Atopic Dermatitis
1 trial -
Roflumilast Cream 0.3%
Arcutis Biotherapeutics
Plaque Psoriasis
1 trial -
Roflumilast Foam 0.3%
Arcutis Biotherapeutics
Seborrheic Dermatitis
1 trial -
Roflumilast foam 0.3%
Arcutis Biotherapeutics
Plaque Psoriasis
1 trial -
Roflumilast topical 0.3% foam
Arcutis Biotherapeutics
Non-segmental Vitiligo
1 trial -
Topical roflumilast 0.3% foam
Arcutis Biotherapeutics
Hidradenitis Suppurativa
1 trial -
Roflumilast
Takeda
Schizophrenia
1 trial -
Roflumilast Cream 0.15%
Arcutis Biotherapeutics
ITCH
1 trial -
Roflumilast alternated days
Lxo Ireland Designated Activity Company
Chronic Obstructive Pulmonary Disease (COPD)
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.